MDCG 21-26 – Q&A on repackaging & relabelling activities under Article 16 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746
The document, endorsed by the Medical Device Coordination Group (MDCG), presents questions and answers about obligations introduced by Article 16(2) to (4) under Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).
Read the news announcement published by the European Commission on 21 October 2021.
OpenEdition vous propose de citer ce billet de la manière suivante :
Aurélie Mahalatchimy (14 mars 2022). MDCG 21-26 – Q&A on repackaging & relabelling activities under Article 16 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746. ELSIBI. Consulté le 18 février 2025 à l’adresse https://doi.org/10.58079/o5vj